ReviewAdvances in experimental medicine and biology2026
Use of Nuclear Magnetic Resonance (NMR) to Study Cancer Metabolism.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nuclear magnetic resonance (NMR) spectroscopy has emerged as an important tool in cancer metabolism research, providing noninvasive, quantitative, and revealing insights into tumor biochemistry. This chapter discusses a wide range of NMR applications in oncology, including biofluid metabolomics for early diagnosis and prognosis, high-resolution magic angle spinning (HR-MAS) NMR for intact tissue profiling, and stable isotope-resolved metabolomics (SIRM) for mapping metabolic fluxes. Furthermore, the use of NMR in cancer cell culture models and the transformative influence of dynamic nuclear polarization (DNP)-enhanced NMR for real-time metabolic imaging are addressed. Collectively, these techniques allow for thorough analysis of metabolic reprogramming in cancer, biomarker development, and tailored therapy strategies.
Indexed as
Identifiers
42435182What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.